Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Feb;11(2):666.
doi: 10.1016/j.jaip.2022.11.029.

Polyethylene glycol/polysorbate skin testing can be useful in risk assessment and management of allergic/pseudoallergic reactions to nanolipid/adenoviral vaccines

Francesco Marchi  1 , Anna Carabelli  2
Affiliations
Comment

Polyethylene glycol/polysorbate skin testing can be useful in risk assessment and management of allergic/pseudoallergic reactions to nanolipid/adenoviral vaccines

Francesco Marchi et al. J Allergy Clin Immunol Pract. 2023 Feb.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Greenhawt M., Shaker M., Golden D.B.K. PEG/polysorbate skin testing has no utility in the assessment of suspected allergic reactions to SARS-CoV-2 vaccines. J Allergy Clin Immunol Pract. 2021;9:3321–3322. - PMC - PubMed
    1. Wolfson A.R., Robinson L.B., Li L., McMahon A.E., Cogan A.S., Fu X., et al. First-dose mRNA COVID-19 vaccine allergic reactions: limited role for excipient skin testing. J Allergy Clin Immunol Pract. 2021;9:3308–3320.e3. - PMC - PubMed
    1. Banerji A., Wickner P.G., Saff R., Stone C.A., Jr., Robinson L.B., Long A.A., et al. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach. J Allergy Clin Immunol Pract. 2021;9:1423–1437. - PMC - PubMed
    1. Wenande E., Garvey L.H. Immediate-type hypersensitivity to polyethylene glycols: a review. Clin Exp Allergy. 2016;46:907–922. - PubMed
    1. Brockow K., Mathes S., Fischer J., Volc S., Darsow U., Eberlein B., et al. Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis. Allergy. 2022;77:2200–2210. - PMC - PubMed